This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of compounds targeting neurological conditions such as anxiety, depression, and cognitive impairments. Its structural properties make it valuable for modulating specific receptors or enzymes in the brain, aiding in the development of novel therapeutic agents. Additionally, it is explored for its potential in enhancing the efficacy and selectivity of drugs designed to treat neurodegenerative diseases. Researchers also investigate its role in improving the pharmacokinetic and pharmacodynamic profiles of CNS-targeting medications.